Arrowhead Research - Precio De Mercado

ARWR

67.65

Cambio Diario:

-0.49%

Anual:

85.09%

Precio Día Año
Agios Pharmaceuticals 54.69 -0.35 -0.64% 20.49%
Alnylam Pharmaceuticals 138.88 -0.14 -0.10% 0.29%
Anika Therapeutics 40.21 -0.66 -1.61% 23.95%
Arena Pharmaceuticals 65.90 -2.09 -3.07% 32.52%
Arrowhead Research 67.65 -0.33 -0.49% 85.09%
Bluebird Bio 28.28 -1.44 -4.85% -49.24%
Cerulean Pharma 1.40 -0.09 -6.04% 35.92%
Dicerna Pharmaceuticals 28.96 0.43 1.51% 32.54%
Heron Therapeutics 17.87 0.14 0.79% 19.13%
Intercept Pharmaceuticals 20.28 -0.27 -1.31% -75.05%
YTE 82.68 -0.52 -0.63% -17.32%
Ionis Pharmaceuticals 40.73 -0.25 -0.61% -25.86%
Ligand Pharmaceuticals 150.23 1.35 0.91% 59.85%
Merck & Co 77.47 0.81 1.06% -7.18%
Moderna Inc 170.80 10.92 6.83% 264.57%
Mirati Therapeutics 158.19 -5.86 -3.57% 74.41%
Nektar Therapeutics 19.00 -0.36 -1.86% -2.21%
Novartis 80.87 0.34 0.42% -5.97%
Opko Health 4.34 0.02 0.46% 155.29%
Ultragenyx Pharmaceutical 108.72 -0.86 -0.78% 85.62%
Spectrum Pharmaceuticals 3.00 0.02 0.67% 9.49%
Sarepta Therapeutics 71.80 -0.83 -1.14% -39.43%
TG Therapeutics 44.78 -1.05 -2.29% 282.08%
Vertex Pharmaceuticals 219.39 -1.71 -0.77% -18.88%
Xencor 42.26 -2.42 -5.42% 43.74%

Precio Día Año
NASDAQ 14052 13.58 0.10% 62.45%
Russell 2000 2262 5.60 0.25% 84.09%
S&P MidCap 400 2721 20.80 0.77% 74.27%

ARWR:US
Bienes
Efectivo Y Equivalentes
Activos Circulantes
Pasivo Circulante
DEUDA
EBIT
EBITDA
Eps Ganancias Por Acción
Capital Y Las Reservas
Capital De Préstamo
Capitalización De Mercado
Lngresos Netos
Los Gastos De Explotación
Beneficio Operativo
Capital Social Ordinario
Pe Precio De Ganancias
Beneficio Antes De Impuestos
Ingresos Por Ventas
Gastos De Venta Y Administración
Valores
Acreedores Comerciales
Deudores Comerciales